Lymphoma, T-Cell, Cutaneous
3 competing products in clinical development for Lymphoma, T-Cell, Cutaneous.
Pipeline by Phase
Approved3
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ONTAK (denileukin difitox, DAB389IL-2) | Eisai | Approved | Completed | 43 |
| ONTAK | Eisai | Approved | Completed | 43 |
| ONTAK | Eisai | Approved | Completed | 43 |